Not Rated
Fund Size
(0.01% of Investment in Category)
|
Expense Ratio
(0.52% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 03-Oct-25 | 10149.50 | 1.49% | - | 1.51% | 220/722 |
1 Month | 10-Sep-25 | 10199.50 | 1.99% | - | 2.08% | 156/718 |
3 Month | 10-Jul-25 | 10318.80 | 3.19% | - | 2.25% | 95/693 |
6 Month | 09-Apr-25 | 11167.50 | 11.68% | - | 14.64% | 345/658 |
YTD | 31-Dec-24 | 10205.50 | 2.06% | - | 8.22% | 461/610 |
1 Year | 10-Oct-24 | 10050.20 | 0.50% | 0.50% | 5.19% | 359/563 |
2 Year | 10-Oct-23 | 14383.20 | 43.83% | 19.90% | 16.87% | 122/452 |
3 Year | 10-Oct-22 | 16914.70 | 69.15% | 19.13% | 17.80% | 105/335 |
Since Inception | 26-Oct-20 | 20243.80 | 102.44% | 15.28% | 11.72% | 170/754 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 10-Oct-24 | 12000 | 12604.82 | 5.04 % | 9.45 % |
2 Year | 10-Oct-23 | 24000 | 27179.03 | 13.25 % | 12.44 % |
3 Year | 10-Oct-22 | 36000 | 46487.97 | 29.13 % | 17.31 % |
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
# Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 177.2 | 10.89% | 0.00% | 13.87% (Sep 2024) | 10.84% (Aug 2025) | 1.11 L | 73.00 |
# Max Healthcare Institute Ltd. | Hospital | 100.4 | 6.17% | 0.00% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 90.06 k | 59.00 |
# Cipla Ltd. | Pharmaceuticals | 98.4 | 6.05% | 0.00% | 6.59% (Sep 2024) | 5.7% (Dec 2024) | 65.48 k | 54.00 |
# Apollo Hospitals Enterprises Ltd. | Hospital | 86.4 | 5.31% | 0.00% | 5.46% (Sep 2024) | 4.75% (Feb 2025) | 11.66 k | 8.00 |
# ELI LILLY ORD SHS | Foreign equity | 85.4 | 5.25% | 0.00% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | -12.00 |
# Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.8 | 5.09% | 0.00% | 5.92% (Sep 2024) | 5.08% (Feb 2025) | 67.65 k | 52.00 |
# Divis Laboratories Ltd. | Pharmaceuticals | 78.7 | 4.84% | 0.00% | 6.03% (May 2025) | 4.91% (Sep 2024) | 13.83 k | 9.00 |
# Johnson & Johnson | Foreign equity | 61.9 | 3.80% | 0.00% | 3.62% (Aug 2025) | 2.59% (Sep 2024) | 3.76 k | -40.00 |
# AbbVie Inc | Foreign equity | 56.8 | 3.49% | 0.00% | 3.16% (Aug 2025) | 2.33% (Sep 2024) | 2.76 k | -31.00 |
# Fortis Healthcare Ltd. | Hospital | 55.1 | 3.39% | 0.00% | 3.17% (Aug 2025) | 2.26% (Sep 2024) | 56.83 k | 38.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 0.11% |
Net Receivables | Net Receivables | 0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
ICICI Prudential Silver ETF | NA | 9481.23 | 32.81 | 53.66 | 81.37 | 86.56 | 42.09 |
Aditya Birla Sun Life Silver ETF | NA | 1580.22 | 32.73 | 53.54 | 81.26 | 86.51 | 42.07 |
Axis Silver ETF | NA | 638.38 | 32.66 | 53.43 | 81.08 | 86.30 | 42.04 |
Kotak Silver ETF | NA | 1664.17 | 32.75 | 53.53 | 81.12 | 86.29 | 0.00 |
DSP Silver ETF | NA | 1449.76 | 32.73 | 53.50 | 81.12 | 86.25 | 42.09 |
Mirae Asset Silver ETF | NA | 376.62 | 32.68 | 53.46 | 81.08 | 86.25 | 0.00 |
SBI Silver ETF | NA | 1982.35 | 32.67 | 53.40 | 80.91 | 86.04 | 0.00 |
Nippon India Silver ETF | NA | 10851.84 | 32.69 | 53.43 | 80.94 | 85.88 | 42.16 |
Edelweiss Silver ETF | NA | 293.08 | 32.64 | 53.35 | 80.82 | 85.84 | 0.00 |
HDFC Silver ETF | NA | 2425.57 | 32.76 | 53.51 | 81.12 | 85.52 | 41.91 |
Out of 89 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 5 is/are ranked 4 * , 5 is/are ranked 3 * , 3 is/are ranked 2 * , and 74 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
BHARAT Bond ETF - April 2030 | NA | 25230.21 | 0.91 | 1.41 | 3.74 | 8.43 | 8.50 |
BHARAT Bond ETF - April 2030 | NA | 25230.21 | 0.92 | 1.43 | 3.96 | 8.69 | 8.84 |
Edelweiss Arbitrage Fund - Growth | 4 | 15930.88 | 0.43 | 1.23 | 2.82 | 6.47 | 7.01 |
BHARAT Bond ETF - April 2031 | NA | 13178.26 | 0.97 | 1.37 | 3.43 | 8.25 | 8.57 |
BHARAT Bond ETF - April 2031 | NA | 13178.26 | 0.92 | 1.41 | 3.86 | 8.61 | 8.98 |
Edelweiss Balanced Advantage Fund - Growth | 2 | 12725.34 | 0.90 | 1.40 | 8.64 | 1.17 | 12.93 |
Edelweiss Mid Cap Fund - Regular Plan - Growth | 5 | 11297.33 | 0.28 | 0.92 | 16.89 | -0.09 | 24.93 |
BHARAT Bond ETF - April 2032 | NA | 10684.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BHARAT Bond ETF - April 2032 | NA | 10684.47 | 1.27 | 1.59 | 3.74 | 8.52 | 9.15 |
Edelweiss Liquid Fund - Regular Plan - Growth | 4 | 10217.51 | 0.50 | 1.43 | 3.04 | 6.77 | 6.95 |